Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes. 2014

Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
National Institute for Occupational Safety and Health, 1095 Willowdale Road, Mailstop L-3014, Morgantown, WV 26505, USA. lqs1@cdc.gov.

BACKGROUND Engineered carbon nanotubes are currently used in many consumer and industrial products such as paints, sunscreens, cosmetics, toiletries, electronic processes and industrial lubricants. Carbon nanotubes are among the more widely used nanoparticles and come in two major commercial forms, single-walled carbon nanotubes (SWCNT) and the more rigid, multi-walled carbon nanotubes (MWCNT). The low density and small size of these particles makes respiratory exposures likely. Many of the potential health hazards have not been investigated, including their potential for carcinogenicity. We, therefore, utilized a two stage initiation/promotion protocol to determine whether inhaled MWCNT act as a complete carcinogen and/or promote the growth of cells with existing DNA damage. Six week old, male, B6C3F1 mice received a single intraperitoneal (ip) injection of either the initiator methylcholanthrene(MCA, 10 μg/g BW, i.p.), or vehicle (corn oil). One week after i.p. injections, mice were exposed by inhalation to MWCNT (5 mg/m³, 5 hours/day, 5 days/week) or filtered air (controls) for a total of 15 days. At 17 months post-exposure, mice were euthanized and examined for lung tumor formation. RESULTS Twenty-three percent of the filtered air controls, 26.5% of the MWCNT-exposed, and 51.9% of the MCA-exposed mice, had lung bronchiolo-alveolar adenomas and lung adenocarcinomas. The average number of tumors per mouse was 0.25, 0.81 and 0.38 respectively. By contrast, 90.5% of the mice which received MCA followed by MWCNT had bronchiolo-alveolar adenomas and adenocarcinomas with an average of 2.9 tumors per mouse 17 months after exposure. Indeed, 62% of the mice exposed to MCA followed by MWCNT had bronchiolo-alveolar adenocarcinomas compared to 13% of the mice that received filtered air, 22% of the MCA-exposed, or 14% of the MWCNT-exposed. Mice with early morbidity resulting in euthanasia had the highest rate of metastatic disease. Three mice exposed to both MCA and MWCNT that were euthanized early had lung adenocarcinoma with evidence of metastasis (5.5%). Five mice (9%) exposed to MCA and MWCNT and 1 (1.6%) exposed to MCA developed serosal tumors morphologically consistent with sarcomatous mesotheliomas, whereas mice administered MWCNT or air alone did not develop similar neoplasms. CONCLUSIONS These data demonstrate that some MWCNT exposures promote the growth and neoplastic progression of initiated lung cells in B6C3F1 mice. In this study, the mouse MWCNT lung burden of 31.2 μg/mouse approximates feasible human occupational exposures. Therefore, the results of this study indicate that caution should be used to limit human exposures to MWCNT.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008654 Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) Mesotheliomas
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008859 Microscopy, Polarization Microscopy using polarized light in which phenomena due to the preferential orientation of optical properties with respect to the vibration plane of the polarized light are made visible and correlated parameters are made measurable. Microscopy, Polarized Light,Polarization Microscopy,Light Microscopies, Polarized,Light Microscopy, Polarized,Microscopies, Polarization,Microscopies, Polarized Light,Polarization Microscopies,Polarized Light Microscopies,Polarized Light Microscopy
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D000077192 Adenocarcinoma of Lung A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer. Lung Adenocarcinoma,Adenocarcinoma, Lung,Adenocarcinomas, Lung,Lung Adenocarcinomas
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
July 2013, Particle and fibre toxicology,
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
September 2023, Nanomaterials (Basel, Switzerland),
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
February 2012, Nanotoxicology,
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
February 2013, The Journal of toxicological sciences,
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
June 2013, Journal of toxicologic pathology,
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
January 2010, Journal of toxicology and environmental health. Part A,
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
October 2009, Inhalation toxicology,
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
April 2019, Inhalation toxicology,
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
March 2019, International journal of environmental research and public health,
Linda M Sargent, and Dale W Porter, and Lauren M Staska, and Ann F Hubbs, and David T Lowry, and Lori Battelli, and Katelyn J Siegrist, and Michael L Kashon, and Robert R Mercer, and Alison K Bauer, and Bean T Chen, and Jeffrey L Salisbury, and David Frazer, and Walter McKinney, and Michael Andrew, and Shuji Tsuruoka, and Morinobu Endo, and Kara L Fluharty, and Vince Castranova, and Steven H Reynolds
December 2008, Journal of nanoscience and nanotechnology,
Copied contents to your clipboard!